Abstract
CRISPR/Cas9 genomic editing of wild-type hematopoietic stem cells generates Npm1-Alk, leading to ALK+ large-cell lymphomas in recipients.CD30+ postthymic T-cell lymphomas are polyclonal but transplantable to secondary recipients with long latency.